Total Payments
$11,634
2024 Payments
$584.81
Companies
30
Transactions
496
Medicare Patients
654
Medicare Billing
$97,470
Payment Breakdown by Category
Food & Beverage$9,150 (78.7%)
Travel$2,473 (21.3%)
Education$11.02 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,150 | 484 | 78.7% |
| Travel and Lodging | $2,473 | 10 | 21.3% |
| Education | $11.02 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $3,481 | 24 | $0 (2023) |
| Novo Nordisk Inc | $3,240 | 232 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,230 | 58 | $0 (2024) |
| Abbott Laboratories | $703.12 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $445.94 | 32 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $421.37 | 38 | $0 (2022) |
| Lilly USA, LLC | $391.31 | 27 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $330.73 | 12 | $0 (2018) |
| Amgen Inc. | $227.83 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $211.33 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $584.81 | 26 | Abbott Laboratories ($187.10) |
| 2023 | $4,102 | 55 | Medtronic, Inc. ($3,481) |
| 2022 | $694.73 | 37 | Abbott Laboratories ($197.30) |
| 2021 | $1,155 | 55 | Novo Nordisk Inc ($431.46) |
| 2020 | $930.73 | 57 | Novo Nordisk Inc ($355.09) |
| 2019 | $928.78 | 73 | Novo Nordisk Inc ($611.29) |
| 2018 | $1,476 | 85 | Novo Nordisk Inc ($835.89) |
| 2017 | $1,761 | 108 | Novo Nordisk Inc ($525.24) |
All Payment Transactions
496 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Diabetes Care | ||||||
| 10/30/2024 | Avvisto Therapeutics, LLC | CYCLOSET (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: ANTI-DIABETIC | ||||||
| 10/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Oncology | ||||||
| 10/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $8.60 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Avvisto Therapeutics, LLC | CYCLOSET (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: ANTI-DIABETIC | ||||||
| 08/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Endocrinology | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/21/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Insomnia | ||||||
| 06/18/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $145.20 | General |
| Category: Diabetes Care | ||||||
| 06/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.38 | General |
| Category: Diabetes | ||||||
| 05/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Diabetes | ||||||
| 04/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Diabetes | ||||||
| 03/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Diabetes | ||||||
| 03/06/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Oncology | ||||||
| 03/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Diabetes | ||||||
| 02/28/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Diabetes Care | ||||||
| 02/19/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Obesity | ||||||
| 02/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Obesity | ||||||
| 01/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 232 | 522 | $166,705 | $33,142 |
| 2022 | 5 | 149 | 543 | $112,181 | $21,679 |
| 2021 | 6 | 169 | 341 | $119,445 | $26,399 |
| 2020 | 3 | 104 | 262 | $93,315 | $16,250 |
Total Patients
654
Total Services
1,668
Medicare Billing
$97,470
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 94 | 260 | $122,093 | $21,989 | 18.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 26 | 26 | $16,542 | $4,263 | 25.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 20 | 20 | $8,740 | $2,569 | 29.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 14 | $7,840 | $1,842 | 23.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 16 | 16 | $3,056 | $1,151 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $3,091 | $556.30 | 18.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 17 | 17 | $1,411 | $501.67 | 35.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 28 | $2,632 | $259.21 | 9.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 12 | 130 | $1,300 | $10.76 | 0.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 85 | 243 | $102,668 | $19,734 | 19.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 17 | 17 | $3,247 | $1,165 | 35.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 16 | 16 | $1,328 | $454.08 | 34.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 19 | 27 | $2,538 | $302.08 | 11.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 12 | 240 | $2,400 | $23.81 | 1.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 77 | 234 | $96,408 | $20,548 | 21.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 15 | 16 | $8,960 | $2,092 | 23.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 25 | 25 | $4,487 | $1,562 | 34.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 11 | 11 | $4,807 | $1,482 | 30.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 23 | 23 | $1,845 | $378.56 | 20.5% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 18 | 32 | $2,938 | $336.11 | 11.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 74 | 227 | $90,496 | $15,983 | 17.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 18 | 22 | $1,987 | $208.56 | 10.5% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2020 | 12 | 13 | $832.00 | $58.45 | 7.0% |
About Dr. Jill Wolf, MD
Dr. Jill Wolf, MD is a Internal Medicine healthcare provider based in Little Elm, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1093792418.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jill Wolf, MD has received a total of $11,634 in payments from pharmaceutical and medical device companies, with $584.81 received in 2024. These payments were reported across 496 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($9,150).
As a Medicare-enrolled provider, Wolf has provided services to 654 Medicare beneficiaries, totaling 1,668 services with total Medicare billing of $97,470. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Little Elm, TX
- Active Since 12/28/2005
- Last Updated 03/07/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1093792418
Products in Payments
- Ozempic (Drug) $1,247
- MICRA (Device) $1,090
- FARXIGA (Drug) $1,069
- Saxenda (Drug) $513.74
- FREESTYLE LIBRE 3 (Device) $331.39
- Victoza (Drug) $286.85
- NURTEC ODT (Drug) $249.11
- INVOKANA (Drug) $217.49
- JANUVIA (Drug) $217.47
- Tresiba (Drug) $205.76
- XARELTO (Drug) $197.86
- JARDIANCE (Drug) $181.15
- BELSOMRA (Drug) $181.00
- Rybelsus (Drug) $180.01
- FREESTYLE LIBRE 2 (Device) $176.68
- ENTRESTO (Drug) $164.87
- FreeStyle Libre 2 (Device) $161.31
- Repatha (Biological) $148.84
- TRULICITY (Drug) $142.25
- Wegovy (Drug) $138.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Little Elm
Dr. John Flores, Md, MD
Internal Medicine — Payments: $115,415
Internal Medicine $115,415
Ajay Pathak, M.d, M.D
Internal Medicine — Payments: $20,951
Internal Medicine $20,951
Taek Soo Shin, M.d, M.D
Internal Medicine — Payments: $481.17
Internal Medicine $481.17
Dr. Sarah Khan-Atif, Md, MD
Internal Medicine — Payments: $472.74
Internal Medicine $472.74
Dr. Ramesh Chandran, M.d, M.D
Internal Medicine — Payments: $46.99
Internal Medicine $46.99